Introduction: Since 1998 Poland has endorsed measles elimination programme which is coordinated by the World Health Organization (WHO). To accomplish measles elimination in the country, achievement of vaccination coverage at 95% in the population is needed, as is the monitoring of the epidemiological situation, i.e.: reporting on cases suspected of measles and conducting laboratory diagnostics in WHO Reference Laboratory. Polish Reference Laboratory is located at the Department of Virology NIPH-NIH.
Objectives: The aim of the article is to analyze the epidemiological situation of measles in Poland in 2018 with presenting the measles vaccination coverage and the progress of the measles elimination programme in Poland.
Material And Methods: The epidemiological situation of measles in Poland was analyzed on the basis of the case-based questionnaires of cases suspected of measles sent to NIPH-NIH by the Sanitary and Epidemiological Stations, data from the publications: "Infectious diseases and poisonings in Poland in 2018" and "Vaccinations in Poland in 2018".
Results: In 2018, 359 cases of measles were notified to the surveillance system in Poland (incidence 2.94 per 100 000 population). The highest incidence was observed in the age 1 and was estimated at 4.06 per 100 000 population. Out of all cases, 209 (58.2%) were hospitalized. No fatal cases due to the measles were reported. In 2018 the maintenance of high vaccination coverage among children aged 2 and 12 years old was observed - from 92.9% to 99.3% (primary vaccination, children born in 2008-2016) and from 92.4% to 97.8% (booster vaccination, children born in 2005-2010).
Conclusions: The epidemiological situation of measles in 2018 in comparison with the situation in 2017, has deteriorated. This was a trend in throughout Europe.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.32394/pe.74.32 | DOI Listing |
Prev Med
January 2025
Department of Environmental Health Sciences, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA; Department of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, USA; School of Nursing, University of California Los Angeles, Los Angeles, CA, USA. Electronic address:
Aims: Cardiovascular disease (CVD) is the leading cause of death in the United States (U.S.).
View Article and Find Full Text PDFJ Occup Environ Med
November 2024
Department of Environmental Epidemiology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Japan.
Objectives: To clarify the association between telework with family members at home and work functioning impairment.
Methods: A cross-sectional survey was conducted in 27,036 participants. Having children or cohabitants in need of care at home during telework was considered an exposure factor.
Blood Transfus
December 2024
National Blood Centre, Istituto Superiore di Sanità, Rome, Italy.
Parvovirus B19 (B19V) presents a significant concern in the context of blood transfusion safety, given its potential for transmission through contaminated blood products, and the increased viral circulation recently reported across Europe. This study examines the recent epidemiological trends of B19V in Italy, where a notable increase in B19V-positive plasma units was observed during early 2024. While routine NAT testing for B19V in individual blood donations is not currently justified, the existing screening protocols for plasma intended for industrial fractionation are crucial to ensure the safety of plasma-derived medicinal products.
View Article and Find Full Text PDFJMIR Public Health Surveill
January 2025
Buehler Center for Health Policy and Economics, Robert J. Havey, MD Institute for Global Health, Northwestern University, 420 E. Superior, Chicago, US.
Background: This study updates the COVID-19 pandemic surveillance in East Asia and the Pacific we first conducted in 2020 with two additional years of data for the region.
Objective: First, we measure whether there was an expansion or contraction of the pandemic in East Asia and the Pacific region when the World Health Organization (WHO) declared the end of the COVID-19 public health emergency of international concern on May 5, 2023. Second, we use dynamic and genomic surveillance methods to describe the dynamic history of the pandemic in the region and situate the window of the WHO declaration within the broader history.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!